FibroGen (FGEN) News Today → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free FGEN Stock Alerts $2.17 +0.08 (+3.83%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFibroGen, Inc. (NASDAQ:FGEN) CEO Thane Wettig Buys 50,000 Shares of Stockamericanbankingnews.com - March 12 at 5:06 AMInsider Buying: FibroGen, Inc. (NASDAQ:FGEN) CEO Buys 50,000 Shares of Stockinsidertrades.com - March 12 at 5:04 AMFibroGen, Inc. (NASDAQ:FGEN) CEO Thane Wettig Buys 50,000 Sharesmarketbeat.com - March 11 at 7:47 PMFibroGen, Inc.: FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officerfinanznachrichten.de - March 11 at 10:13 AMFibroGen Appoints Deyaa Adib As CMOmarkets.businessinsider.com - March 11 at 10:13 AMFibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officerglobenewswire.com - March 11 at 7:00 AMArmistice Capital LLC Purchases 3,536,000 Shares of FibroGen, Inc. (NASDAQ:FGEN)marketbeat.com - March 3 at 10:50 AMWilliam Blair Weighs in on FibroGen, Inc.'s Q2 2024 Earnings (NASDAQ:FGEN)marketbeat.com - February 29 at 8:38 AMUS$1.25: That's What Analysts Think FibroGen, Inc. (NASDAQ:FGEN) Is Worth After Its Latest Resultsfinance.yahoo.com - February 29 at 8:20 AMFibroGen, Inc. (NASDAQ:FGEN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 29 at 8:20 AMFibroGen Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - February 28 at 7:17 AMAcadian Asset Management LLC Purchases Shares of 1,615,094 FibroGen, Inc. (NASDAQ:FGEN)marketbeat.com - February 28 at 5:45 AMFibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - February 27 at 9:44 AMFibroGen (NASDAQ:FGEN) Rating Reiterated by William Blairmarketbeat.com - February 27 at 9:33 AMFibroGen Inc (FGEN) Reports Modest Revenue Growth and Reduced Net Loss in FY 2023finance.yahoo.com - February 26 at 7:33 PMFibroGen regains rights to anemia drug from AstraZenecareuters.com - February 26 at 4:18 PMFibroGen Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - February 26 at 4:06 PMFibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZeneca Territories, Except China and South Koreaglobenewswire.com - February 26 at 4:05 PMPrimecap Management Co. CA Has $12.71 Million Stake in FibroGen, Inc. (NASDAQ:FGEN)marketbeat.com - February 26 at 8:56 AMHere's what Wall Street expects from FibroGen's earnings reportmarkets.businessinsider.com - February 25 at 9:18 AMFGEN Jan 2026 1.000 callfinance.yahoo.com - February 24 at 1:52 PMFibroGen's Earnings Outlookbenzinga.com - February 23 at 2:53 PMFibroGen Stock (NASDAQ:FGEN) Insider Tradesbenzinga.com - February 21 at 7:27 PMFirst Gen Corp FGENmorningstar.com - February 21 at 2:26 PMFibroGen (FGEN) Set to Announce Earnings on Mondaymarketbeat.com - February 21 at 8:58 AMFGEN Jan 2025 3.500 callfinance.yahoo.com - February 20 at 1:31 PMFibroGen to Report Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - February 20 at 8:31 AMFibroGen to Report Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - February 20 at 7:00 AMFGEN Jan 2025 2.500 putfinance.yahoo.com - February 17 at 9:30 AMFGEN Mar 2024 2.000 callfinance.yahoo.com - February 17 at 12:28 AMSell Rating on FibroGen Amid Skepticism Over Clinical Outcomes and Drug Efficacymarkets.businessinsider.com - February 15 at 3:32 PMFibroGen, Inc. (NASDAQ:FGEN) Given Consensus Rating of "Reduce" by Analystsmarketbeat.com - February 13 at 1:58 AMFGEN Jan 2025 3.500 putca.finance.yahoo.com - February 10 at 8:54 PMFibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024finance.yahoo.com - February 5 at 10:11 AMFibroGen, Inc. (NASDAQ:FGEN) Shares Acquired by Assenagon Asset Management S.A.marketbeat.com - February 4 at 5:03 AMFibroGen Target of Unusually High Options Trading (NASDAQ:FGEN)marketbeat.com - January 30 at 1:36 PMFibroGen, Inc. (NASDAQ:FGEN) institutional owners may be pleased with recent gains after 96% loss over the past yearfinance.yahoo.com - January 27 at 12:01 PMFibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancerfinance.yahoo.com - January 25 at 7:52 AMFibroGen, Inc. (FGEN) Interactive Stock Chart - Yahoo Financeca.finance.yahoo.com - January 21 at 9:59 AMFIBROGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating FibroGen, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firmbusinesswire.com - December 27 at 4:05 AMFibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meetingfinance.yahoo.com - December 9 at 5:54 PMFibroGen, Inc. (FGEN) stock price, news, quote & history – Yahoo Financesg.finance.yahoo.com - December 4 at 9:31 AMFibroGen Inc FGENmorningstar.com - November 11 at 3:35 PMFibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 7 at 3:51 PMFibroGen (FGEN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimatesfinance.yahoo.com - November 6 at 9:43 PMFibroGen Inc (FGEN) Reports 155% YoY Increase in Q3 2023 Net Revenuefinance.yahoo.com - November 6 at 9:43 PMFibroGen Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 6 at 4:43 PMFibroGen earnings: here's what Wall Street expectsmarkets.businessinsider.com - November 5 at 10:41 AMBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Fibrogen, Inc. (FGEN) Investigationbarrons.com - October 29 at 2:05 PMFibroGen to Report Third Quarter 2023 Financial Resultsfinance.yahoo.com - October 23 at 9:28 AM Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Like Tiny Crypto Retirement Funds (Ad)The crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. FGEN Media Mentions By Week FGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FGEN News Sentiment▼1.030.64▲Average Medical News Sentiment FGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FGEN Articles This Week▼23▲FGEN Articles Average Week Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Theseus Pharmaceuticals News Today Kinnate Biopharma News Today Seres Therapeutics News Today Inovio Pharmaceuticals News Today Mind Medicine (MindMed) News Today Ocuphire Pharma News Today Avid Bioservices News Today Gracell Biotechnologies News Today CorMedix News Today Trevi Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FGEN) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetryThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.